Business Wire

PacSci EMC Proves Propulsion Technology on Demonstrator Satellite

Del

PacSci EMC successfully completed propulsion technology tests with its on-orbit technology demonstrator satellite, PACSCISAT, on August 1, 2017. Over the past month of continuing on-orbit operations in a 515 km, sun-synchronous, polar orbit, PacSci EMC successfully passed built-in-tests (BIT) on both its primary and redundant Smart Energetics Architecture (SEA™) sequencing system and devices and fired Modular Architecture Propulsion System (MAPS™) rocket motors. MAPS precision impulse rocket motors changed PACSCISAT’s orbital velocity and altitude exactly as predicted by orbital models.

“This phase of the mission proved that our MAPS technology performs reliably and precisely as commanded and is now at technology readiness level 9 (TRL-9),” said Greg Scaven, PacSci EMC’s president. “Our goal with this mission was to answer the question ‘has MAPS flown in space before?’ and now the answer is yes. We believe our MAPS technology will be a game changer for the NewSpace market providing very precise and predictable orbital maneuvering capability for CubeSats, SmallSats and small upper stage systems.”

MAPS is an array of high performance, sealed, solid propellant rocket motors which extends the orbital life of CubeSats, SmallSats and provides propulsion capability for small upper stages. MAPS can be used for orbital maneuvers and deorbit with very precise and predictable delivered impulse and has no tanks, valves, tubing or heaters making it a “plug and play”, bolt-on design. MAPS is instant on with 10+year life, uses very low power, has three independent inhibits against firing, and provides variable thrust by firing in pairs, triples, quads, etc. MAPS is adaptable & scalable and fits in unused separation system or other spacecraft real-estate.

PacSci EMC products are used in all phases of vehicle flight beginning with ground-based operations through lift-off/boost, solid rocket booster jettison, payload fairing separation, booster separation, second stage flight, payload separation and flight termination.

PACSCISAT successfully built and commanded by Tyvak, a Terran Orbital Corporation, with its PacSci EMC MAPS payload, was launched on June 22, 2017 on the Polar Satellite Launch Vehicle flight C38 (PSLV-C38) from the Satish Dhawan Space Centre in India.

ABOUT PACIFIC SCIENTIFIC ENERGETIC MATERIALS COMPANY LLC (PacSci EMC):

PacSci EMC provides pyrotechnic and energetic material devices and integrated systems that operate precisely the moment they are commanded – down to the millisecond. The safe and reliable operation of our products drives PacSci EMC from development, design and testing to manufacturing and final assembly. From critical systems such as aircraft emergency safety systems to sequencing systems for strategic and tactical missiles, our components can be found in hundreds of applications. Our innovations in environmentally conscious energetic materials along with our propulsion and sequencing systems are a result of over 65 years of experience working for customers in commercial aerospace, military, space, oil and gas, and law enforcement.

Contact information

Pacific Scientific Energetic Materials Company (PacSci EMC)
Steve Nelson, 661-917-2947
snelson@psemc.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Lenovo Attains Status as Largest Global Provider of TOP500 Supercomputers25.6.2018 07:01Pressemelding

Today, at the International Supercomputing Conference (ISC) in Frankfurt, Lenovo Data Center Group (HKSE: 992) (ADR: LNVGY) continued its global momentum, becoming the world’s largest TOP500 supercomputing provider measured by the number of systems ranked on the TOP500 list. 117 of the 500 most powerful supercomputers included in the TOP500 are Lenovo installations, meaning nearly one out of every four systems (23.4 percent) on the prestigious list is a Lenovo solution. “Last year, we set a goal to become the world’s largest provider of TOP500 computing systems by 2020. We have reached that goal two years ahead of our original plan,” said Kirk Skaugen, President of Lenovo Data Center Group. “This distinction is a testament to our commitment to prioritize customer satisfaction, deliver cutting edge innovation and performance and be the world’s most trusted data center partner. We are motivated every day by the scientists and their groundbreaking research as we work together to solve hum

XebiaLabs Unveils “Periodic Table of DevOps Tools” v.3 at DevOps Enterprise Summit London 201825.6.2018 07:00Pressemelding

XebiaLabs, the recognized leader in Enterprise DevOps and Continuous Delivery software, today announced the release of The Periodic Table of DevOps Tools v.3, an update of its free, industry-recognized DevOps landscape tool. The latest release of this acclaimed tool features 52 new DevOps tools, a new design, and the addition of categories, such as Analytics and AIOps, to reflect the expanding DevOps tools and technologies market. In addition, users can select a tool in the Periodic Table and immediately visualize it in the software delivery pipeline using XebiaLabs’ integrated DevOps Diagram Generator. DevOps pipeline diagrams can be easily customized, downloaded, printed, and shared. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180625005106/en/ XebiaLabs Unveils “Periodic Table of DevOps Tools” v.3 at DevOps Enterprise Summit London 2018 (Graphic: Business Wire) Given the fast pace at which new DevOps tools become availa

Enterprise DevOps for the Cloud25.6.2018 07:00Pressemelding

XebiaLabs, the recognized leader in enterprise DevOps and Continuous Delivery software, today announced a DevOps framework that provides a smooth pathway to the cloud for companies who are moving applications to cloud-based resources on a large scale. The framework connects enterprise DevOps practices with common cloud management functionality and provides an essential foundation as enterprises accelerate their transformations to cloud-based applications. Cloud Does Not Equal DevOps Easy access to public cloud technologies creates a common misconception: moving to the cloud will not only provide more flexible and scalable infrastructure at a lower cost, but it will also accelerate the delivery of applications to the customer. In reality, moving to the cloud is just one step in that journey. Enterprises that are looking to improve and accelerate software delivery are implementing DevOps practices that span the entire software delivery value stream. These practices are generally unrelate

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00Pressemelding

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,